Increasing evidence is highlighting the relationship between malignancy and hypercoagulability as a bidirectional association. We herein share our experience with a patient in whom such an association may be entertained. The patient, who had a history of venous thromboembolism, presented to our care with manifestation of stroke. Extensive workup revealed that the patient carries prothrombotic mutations in the prothrombin and methylenetetrahydrofolate reductase genes. The patient, a non-smoker, was also diagnosed with non-small cell lung carcinoma. The possible association between the patient’s malignancy and prothrombotic state are further discussed.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Agnelli G, Verso M (2005) Thrombosis and cancer: clinical relevance of a dangerous liaison. Haematologica 90:155–156
Franchini M, Veneri D, Salvagno GL et al (2006) Inherited thrombophilia. Crit Rev Clin Lab Sci 43:249–290
Hankey GJ, Eikelboom JW, van Bockxmeer FM et al (2001) Inherited thrombophilia in ischemic stroke and its pathogenic subtypes. Stroke 32:1793–1799
Graus F, Rogers LR, Posner JB (1985) Cerebrovascular complications in patients with cancer. Medicine (Baltimore) 64:16–35
Taccone FS, Jeangette SM, Blecic SA (2008) First-ever stroke as initial presentation of systemic cancer. J Stroke Cerebrovasc Dis 17:169–174
Decousus H, Moulin N, Quenet S et al (2007) Thrombophilia and risk of venous thrombosis in patients with cancer. Thrombosis Res 120(Suppl 2):S51–S61
Rickles FR, Patierno S, Fernandez PM (2003) Tissue factor, thrombin, and cancer. Chest 124(Suppl 3):S58–S68
Vairaktaris E, Yapijakis C, Wiltfang J et al (2005) Are factor V and prothrombin mutations associated with increased risk of oral cancer? Anticancer Res 25:2561–2565
Batistelli S, Stefanoni M, Genovese A et al (2006) Prevalence of factor V leiden and prothrombin G20210A in patients with gastric cancer. World J Gastrornterol 12:4179–4180
Smorenburg SM, Van Noorden CJF (2001) The complex effects of heparins on cancer progression and metastasis in experimental studies. Pharmacol Rev 53:93–105
Kuderer NM, Khorana AA, Lyman GH, Francis CW (2007) A meta-analysis and systematic review of the efficacy and safety of anticoagulants as cancer treatment: impact on survival and bleeding complications. Cancer 110:1149–1160
About this article
Cite this article
Aoun, E.G., Musallam, K.M., Abou-Ghazal, M. et al. Malignancy and hypercoagulability: a two-way association revisited. J Thromb Thrombolysis 30, 340–341 (2010). https://doi.org/10.1007/s11239-010-0458-4
- Lung cancer
- Venous thromboembolism